Mattson et al. described increased levels of Neuroendocrine protein 7B2 in the CSF of patients with frontotemporal dementia (FTD) with high expression of neurofilament [23] In this study we found decreased levels of this peptide in the CSF of VaD patients compared to AD patients. Here, SCG5 is linked to frontotemporal dementia.